cas 955663-63-5|| where to buy 3-(2-chlorophenyl)-5-methyl-N-[2-(2-methylpropanoyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]-1,2-oxazole-4-carboxamide

Nombre del producto:3-(2-chlorophenyl)-5-methyl-N-[2-(2-methylpropanoyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]-1,2-oxazole-4-carboxamide

IUPAC Name:3-(2-chlorophenyl)-5-methyl-N-[2-(2-methylpropanoyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]-1,2-oxazole-4-carboxamide

Unidad de embalaje	Stock disponible	Precio($)	Cantidad

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 955663-63-5 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :955663-63-5; Fórmula molecular:C24H24ClN3O3; Punto de fusión:-; Código de sonrisas:CC(C)C(=O)N1CCC2=C(C1)C=C(NC(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1)C=C2; Densidad:

: Número de catálogo:CM846499; Peso molecular:437.92; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Isoxazoles; Isoxazole is a liquid heterocyclic compound C3H3NO isomeric with oxazole and having a penetrating odor like that of pyridine. Isoxazoles belong to an important class of five-membered aromatic heterocycles containing two electronegative heteroatoms, nitrogen and oxygen, in a 1,2-relationship and three regular sp2 carbon atoms. These molecules are found to be key components in various synthetic products in daily use and also present as a pharmacophore essential for biological activity in many drugs and bioactive natural products. In addition, isoxazoles have demonstrated their ability to exhibit hydrogen bond donor/acceptor interactions with a variety of enzymes and receptors.

: Tetrahydroisoquinolines; Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.